This series discusses FDA approved COVID-19 therapies for both the inpatient and outpatient settings, off label therapies, and preventive modalities. This roundtable features a panel of clinicians including Tina Tan, MD, Scott Roberts, MD, James Wilson, DO, FACP, FAWM, CTropMed, and Michael Curulewski, PharmD, BCPS, BCIDP, BCGP.
This series discusses Long COVID's prevalence, noting that one in five Americans and one in ten COVID patients may be affected. It features a panel of experts including Ravindra Ganesh, MD, MBBS, FACP, Dip ABOM, Svetlana Blitshteyn, MD, FAAN, and Monica Verduzco-Gutierrez, MD.
This series covers several aspects of HIV care, including clinical management, therapies, vaccines, and multidrug resistance. The panel features MJ Kasten, MD; Natasha Hoyte, MPH, CPNP-PC; Aimalohi Ahonkhai, MD, MPH; and Jessica Castilho, MD.
This series discusses several topics around these infections, including challenges in managing UTIs in patients with dementia and neurogenic bladders, antibiotic resistance, and considerations for patient and caregiver engagement. The panel features Barbara Trautner, MD, PhD; Kimberly Claeys, PharmD; and Laila Woc-Colburn, MD.
This panel features Robert H. Hopkins Jr., MD; William Muller, MD, PhD; Sallie Permar, MD, PhD; Laura Riley, MD; and Neil Silverman, MD, who discuss respiratory syncytial virus, including incidence rates, preventative vaccines and immunizations, and how new prophylactic modalities can curb infections.
